Whan In Pharm Co.,Ltd.

KSE 016580.KS

Whan In Pharm Co.,Ltd. Shares (Diluted, Weighted) for the year ending December 31, 2023: 15,267,070

Whan In Pharm Co.,Ltd. Shares (Diluted, Weighted) is 15,267,070 for the year ending December 31, 2023, a 0.00% change year over year. Shares (diluted, weighted) are the number of outstanding shares used to calculate earnings per share (EPS) assuming the conversion of all potentially dilutive securities.

Whan In Pharm Co.,Ltd. Shares (Diluted, Weighted) for the year ending December 31, 2022 was 15,267,070, a 0.00% change year over year.
Whan In Pharm Co.,Ltd. Shares (Diluted, Weighted) for the year ending December 31, 2021 was 15,267,070, a 0.00% change year over year.
Whan In Pharm Co.,Ltd. Shares (Diluted, Weighted) for the year ending December 31, 2020 was 15,267,070, a 0.00% change year over year.
Whan In Pharm Co.,Ltd. Shares (Diluted, Weighted) for the year ending December 31, 2019 was 15,267,070, a -0.03% change year over year.

Key data

Date	Shares (Diluted, Weighted)	Revenue	Cost of Revenue	Gross Profit

KSE: 016580.KS

Whan In Pharm Co.,Ltd.

CEO	Mr. Wonbum Lee
IPO Date	Jan. 4, 2000
Location	South Korea
Headquarters	Whanin Building, 11
Employees	582
Sector	Healthcare
Industries Pharmaceuticals Biotechnology Cosmetics Drugstores & Retail Pharmacies Personal Care

Description

Whan In Pharm Co.,Ltd., a pharmaceutical company, develops, manufactures, markets, and sells therapeutic products in South Korea. It offers anti-depressants, anti-psychotics, nootropics and anti-dementia, anti-epileptics, cardiovascular, gastrointestinal, antibiotics, antiviral agents, antihistamines, anti-inflammatory and analgesics, metabolic disorders, respiratory, central nervous system, other drug products. The company was founded in 1978 and is headquartered in Seoul, South Korea.

Key trends

Past 5 years